CATH Superfamily 2.60.120.970
The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 5: Bone morphogenetic protein 4
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 16 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
BMP receptor binding GO:0070700
Interacting selectively and non-covalently with a BMP receptor.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
4 | P12644 (/IPI) P12644 (/IPI) P21275 (/IPI) P21275 (/IPI) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Co-receptor binding GO:0039706
Interacting selectively and non-covalently with a coreceptor. A coreceptor acts in cooperation with a primary receptor to transmit a signal within the cell.
|
2 | P12644 (/IPI) P12644 (/IPI) |
Co-receptor binding GO:0039706
Interacting selectively and non-covalently with a coreceptor. A coreceptor acts in cooperation with a primary receptor to transmit a signal within the cell.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P21275 (/ISO) P21275 (/ISO) |
BMP receptor binding GO:0070700
Interacting selectively and non-covalently with a BMP receptor.
|
2 | P12644 (/IDA) P12644 (/IDA) |
BMP receptor binding GO:0070700
Interacting selectively and non-covalently with a BMP receptor.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
1 | Q06826 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | Q06826 (/IDA) |
There are 479 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Regulation of cell fate commitment GO:0010453
Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
|
8 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) Q90752 (/ISS) |
Positive regulation of epidermal cell differentiation GO:0045606
Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
|
8 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) Q90752 (/ISS) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Endochondral ossification GO:0001958
Replacement ossification wherein bone tissue replaces cartilage.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:0002043
The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Lymphoid progenitor cell differentiation GO:0002320
The process in which a precursor cell type acquires the specialized features of a lymphoid progenitor cell. Lymphoid progenitor cells include progenitor cells for any of the lymphoid lineages.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway involved in heart induction GO:0003130
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to heart induction.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Secondary heart field specification GO:0003139
The process that results in the delineation of a specific region of the lateral mesoderm into the area which will form the majority of the mesodermal component of the right ventricle, arterial pole (outflow tract) and venous pole (inflow tract).
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Type B pancreatic cell development GO:0003323
The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
7 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P21275 (/IMP) P21275 (/IMP) P87380 (/IMP) Q06826 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of immature T cell proliferation in thymus GO:0033088
Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Tendon cell differentiation GO:0035990
The process in which a relatively unspecialized cell acquires the specialized features of a tendon cell. Tendon cell are elongated fibrocytes in which the cytoplasm is stretched between the collagen fibres of the tendon. Tendon cells have a central cell nucleus with a prominent nucleolus, a well-developed rough endoplasmic reticulum, and are responsible for synthesis and turnover of tendon fibres and ground substance.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Deltoid tuberosity development GO:0035993
The process whose specific outcome is the progression of the deltoid tuberosity over time, from its formation to the mature structure. The deltoid tuberosity is the region on the shaft of the humerus to which the deltoid muscle attaches. The deltoid tuberosity develops through endochondral ossification in a two-phase process; an initiating tendon-dependent phase, and a muscle-dependent growth phase.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Steroid hormone mediated signaling pathway GO:0043401
A series of molecular signals mediated by a steroid hormone binding to a receptor.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of cardiac muscle fiber development GO:0055020
Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of branching involved in lung morphogenesis GO:0061047
Any process that increases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway involved in ureter morphogenesis GO:0061149
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the shaping of the ureter. The ureter is a tube that extends from the kidney to the bladder.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway involved in renal system segmentation GO:0061151
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the segmentation of the renal system.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Pulmonary artery endothelial tube morphogenesis GO:0061155
The process in which the anatomical structures of a tube are generated and organized from the pulmonary artery endothelium. An pulmonary artery endothelium is an epithelium that lines the pulmonary artery.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of thymocyte apoptotic process GO:0070244
Any process that stops, prevents, or reduces the frequency, rate or extent of thymocyte death by apoptotic process.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway involved in nephric duct formation GO:0071893
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to nephric duct formation.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Glomerular capillary formation GO:0072104
The process that gives rise to a glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Ureter epithelial cell differentiation GO:0072192
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell in the urothelium. The urothelium is the epithelial tube of the ureter.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Ureter smooth muscle cell differentiation GO:0072193
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell in the ureter.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of mesenchymal cell proliferation involved in ureter development GO:0072200
Any process that decreases the frequency, rate or extent of mesenchymal cell proliferation that contributes to the progression of the ureter gland over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Metanephric collecting duct development GO:0072205
The process whose specific outcome is the progression of a collecting duct in the metanephros over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. The collecting duct is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
|
7 | O46576 (/ISS) P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of branching involved in ureteric bud morphogenesis GO:0090191
Any process that decreases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of metanephric S-shaped body morphogenesis GO:2000005
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric S-shaped body morphogenesis.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of metanephric comma-shaped body morphogenesis GO:2000007
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of cell proliferation involved in heart morphogenesis GO:2000137
Any process that stops, prevents, or reduces the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
|
7 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Branching involved in ureteric bud morphogenesis GO:0001658
The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Mesonephros development GO:0001823
The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Mesenchymal to epithelial transition involved in metanephros morphogenesis GO:0003337
A transition where a mesenchymal cell establishes apical/basolateral polarity,forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
6 | F1QAD6 (/IDA) O13107 (/IDA) O57574 (/IDA) P21275 (/IDA) P21275 (/IDA) P87380 (/IDA) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Intermediate mesodermal cell differentiation GO:0048392
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Smooth muscle tissue development GO:0048745
The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure.
|
6 | P12644 (/ISS) P12644 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
BMP signaling pathway involved in heart development GO:0061312
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the progression of the heart over time.
|
6 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P21275 (/IMP) P21275 (/IMP) P87380 (/IMP) |
Negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway GO:0072097
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor resulting in the reduction of the frequency, rate or extent of branch elongation involved in ureteric bud branching, the growth of a branch of the ureteric bud along its axis.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway GO:0072101
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor that results in the establishment of the ureteric bud such that there is a similar arrangement in form and relationship of parts along its anterior/posterior axis.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of kidney development GO:0090184
Any process that increases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Negative regulation of glomerulus development GO:0090194
Any process that decreases the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
|
6 | P21275 (/ISS) P21275 (/ISS) Q06826 (/ISS) Q29607 (/ISS) Q2KJH1 (/ISS) Q8MJV5 (/ISS) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
5 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) Q06826 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
5 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) Q06826 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
4 | P12644 (/IMP) P12644 (/IMP) P21275 (/IMP) P21275 (/IMP) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Heart jogging GO:0003146
The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
BMP signaling pathway involved in heart jogging GO:0003303
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the process of heart jogging.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Proepicardium development GO:0003342
The progression of the proepicardium from its formation to the mature structure. The proepicardium is an outpouching of the septum transversum.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
4 | F1QAD6 (/IEP) O13107 (/IEP) O57574 (/IEP) P87380 (/IEP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Notochord development GO:0030903
The process whose specific outcome is the progression of the notochord over time, from its formation to the mature structure. The notochord is a mesoderm-derived structure located ventral of the developing nerve cord. In vertebrates, the notochord serves as a core around which other mesodermal cells form the vertebrae. In the most primitive chordates, which lack vertebrae, the notochord persists as a substitute for a vertebral column.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Embryonic anal fin morphogenesis GO:0035125
The process, occurring in the embryo, by which the anatomical structures of the embryonic anal fin are generated and organized. An anal fin is an unpaired medial fin on the ventral aspect near the caudal end of a fish, which provides lateral stability while swimming.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Determination of pancreatic left/right asymmetry GO:0035469
Determination of the asymmetric location of the pancreas with respect to the left and right halves of the organism.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Cloaca development GO:0035844
The process whose specific outcome is the progression of the cloaca over time, from it's formation to the mature structure. The cloaca is the common chamber into which intestinal, genital and urinary canals open in vertebrates.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Negative regulation of endodermal cell fate specification GO:0042664
Any process that restricts, stops or prevents a cell from specifying into an endoderm cell.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
Cell fate commitment GO:0045165
The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | P12644 (/IGI) P12644 (/IGI) P21275 (/IGI) P21275 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
4 | F1QAD6 (/IDA) O13107 (/IDA) O57574 (/IDA) P87380 (/IDA) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
4 | F1QAD6 (/IGI) O13107 (/IGI) O57574 (/IGI) P87380 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Pronephros development GO:0048793
The process whose specific outcome is the progression of the pronephros over time, from its formation to the mature structure. In mammals, the pronephros is the first of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the pronephros is the fully functional embryonic kidney and is indispensable for larval life.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Positive chemotaxis GO:0050918
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
|
4 | O46576 (/ISS) P21275 (/ISS) P21275 (/ISS) Q2KJH1 (/ISS) |
Notochord cell differentiation GO:0060034
The process in which relatively unspecialized cells acquire specialized structural and/or functional features cells that make up the notochord. Differentiation includes the processes involved in commitment of a cell to a notochord cell fate.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
BMP signaling pathway involved in mesodermal cell fate specification GO:0060803
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to a cell becoming specified to adopt a mesodermal fate.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Determination of heart left/right asymmetry GO:0061371
Determination of the asymmetric location of the heart with respect to the left and right halves of the organism.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Determination of liver left/right asymmetry GO:0071910
Determination of the asymmetric location of the liver with respect to the left and right halves of the organism.
|
4 | F1QAD6 (/IMP) O13107 (/IMP) O57574 (/IMP) P87380 (/IMP) |
Negative regulation of branching involved in ureteric bud morphogenesis GO:0090191
Any process that decreases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
4 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
3 | A5HMF8 (/IMP) A5HMF9 (/IMP) Q90752 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
3 | P12644 (/IDA) P12644 (/IDA) Q06826 (/IDA) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
3 | P12644 (/IDA) P12644 (/IDA) Q06826 (/IDA) |
Embryonic skeletal system morphogenesis GO:0048704
The process in which the anatomical structures of the skeleton are generated and organized during the embryonic phase.
|
3 | P21275 (/IMP) P21275 (/IMP) Q90752 (/IMP) |
Cloacal septation GO:0060197
The separation of the single opening of the digestive, urinary, and reproductive tracts, the cloaca, into multiple isolated openings during development.
|
3 | P21275 (/IEP) P21275 (/IEP) Q90752 (/IEP) |
Mesenchymal cell proliferation involved in ureteric bud development GO:0072138
The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population of the ureteric bud, that contributes to ureteric bud development.
|
3 | P21275 (/IEP) P21275 (/IEP) Q90752 (/IEP) |
Mesenchymal cell proliferation involved in ureter development GO:0072198
The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population of the ureter, that contributes to ureter development.
|
3 | P21275 (/IEP) P21275 (/IEP) Q90752 (/IEP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
2 | P12644 (/IDA) P12644 (/IDA) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
2 | P21275 (/ISO) P21275 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | P21275 (/IDA) P21275 (/IDA) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | P21275 (/IMP) P21275 (/IMP) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Metanephros development GO:0001656
The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Metanephros development GO:0001656
The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Branching involved in ureteric bud morphogenesis GO:0001658
The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Branching involved in ureteric bud morphogenesis GO:0001658
The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Branching involved in ureteric bud morphogenesis GO:0001658
The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Organ induction GO:0001759
The interaction of two or more cells or tissues that causes them to change their fates and specify the development of an organ.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesonephros development GO:0001823
The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
|
2 | P12644 (/IEP) P12644 (/IEP) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Regulation of endothelial cell proliferation GO:0001936
Any process that modulates the frequency, rate, or extent of endothelial cell proliferation.
|
2 | P21275 (/TAS) P21275 (/TAS) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Endochondral ossification GO:0001958
Replacement ossification wherein bone tissue replaces cartilage.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:0002043
The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:0002043
The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Lymphoid progenitor cell differentiation GO:0002320
The process in which a precursor cell type acquires the specialized features of a lymphoid progenitor cell. Lymphoid progenitor cells include progenitor cells for any of the lymphoid lineages.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Lymphoid progenitor cell differentiation GO:0002320
The process in which a precursor cell type acquires the specialized features of a lymphoid progenitor cell. Lymphoid progenitor cells include progenitor cells for any of the lymphoid lineages.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Renal system process GO:0003014
A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila).
|
2 | P21275 (/IMP) P21275 (/IMP) |
BMP signaling pathway involved in heart induction GO:0003130
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to heart induction.
|
2 | P12644 (/IMP) P12644 (/IMP) |
BMP signaling pathway involved in heart induction GO:0003130
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to heart induction.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Secondary heart field specification GO:0003139
The process that results in the delineation of a specific region of the lateral mesoderm into the area which will form the majority of the mesodermal component of the right ventricle, arterial pole (outflow tract) and venous pole (inflow tract).
|
2 | P12644 (/IMP) P12644 (/IMP) |
Secondary heart field specification GO:0003139
The process that results in the delineation of a specific region of the lateral mesoderm into the area which will form the majority of the mesodermal component of the right ventricle, arterial pole (outflow tract) and venous pole (inflow tract).
|
2 | P21275 (/ISO) P21275 (/ISO) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Pulmonary valve morphogenesis GO:0003184
The process in which the structure of the pulmonary valve is generated and organized.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Pulmonary valve morphogenesis GO:0003184
The process in which the structure of the pulmonary valve is generated and organized.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Cardiac septum development GO:0003279
The progression of a cardiac septum over time, from its initial formation to the mature structure.
|
2 | P12644 (/TAS) P12644 (/TAS) |
Type B pancreatic cell development GO:0003323
The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Type B pancreatic cell development GO:0003323
The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesenchymal to epithelial transition involved in metanephros morphogenesis GO:0003337
A transition where a mesenchymal cell establishes apical/basolateral polarity,forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Mesenchymal to epithelial transition involved in metanephros morphogenesis GO:0003337
A transition where a mesenchymal cell establishes apical/basolateral polarity,forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Smoothened signaling pathway GO:0007224
A series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened.
|
2 | P12644 (/IEP) P12644 (/IEP) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Mesodermal cell fate determination GO:0007500
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Tissue development GO:0009888
The process whose specific outcome is the progression of a tissue over time, from its formation to the mature structure.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Anterior/posterior axis specification GO:0009948
The establishment, maintenance and elaboration of the anterior/posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Specification of animal organ position GO:0010159
The regionalization process in which information that determines the correct position at which animal organ primordia are formed is generated and perceived resulting in correct positioning of the new animal organ.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Regulation of cell fate commitment GO:0010453
Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Regulation of cell fate commitment GO:0010453
Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of calcium ion transport into cytosol GO:0010524
Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
2 | P21275 (/TAS) P21275 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
2 | P21275 (/ISO) P21275 (/ISO) |
Telencephalon development GO:0021537
The process whose specific outcome is the progression of the telencephalon over time, from its formation to the mature structure. The telencephalon is the paired anteriolateral division of the prosencephalon plus the lamina terminalis from which the olfactory lobes, cerebral cortex, and subcortical nuclei are derived.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Telencephalon development GO:0021537
The process whose specific outcome is the progression of the telencephalon over time, from its formation to the mature structure. The telencephalon is the paired anteriolateral division of the prosencephalon plus the lamina terminalis from which the olfactory lobes, cerebral cortex, and subcortical nuclei are derived.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Dorsal/ventral neural tube patterning GO:0021904
The process in which the neural tube is regionalized in the dorsoventral axis.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Telencephalon regionalization GO:0021978
The regionalization process that creates areas within the forebrain that will direct the behavior of cell migration in differentiation as the telencephalon develops.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Telencephalon regionalization GO:0021978
The regionalization process that creates areas within the forebrain that will direct the behavior of cell migration in differentiation as the telencephalon develops.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Pituitary gland development GO:0021983
The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
2 | P21275 (/ISO) P21275 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P21275 (/IGI) P21275 (/IGI) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P12644 (/IMP) P12644 (/IMP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
|
2 | P21275 (/IGI) P21275 (/IGI) |
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
|
2 | P21275 (/TAS) P21275 (/TAS) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of chondrocyte differentiation GO:0032331
Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of T cell differentiation in thymus GO:0033085
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation in the thymus.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Negative regulation of T cell differentiation in thymus GO:0033085
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation in the thymus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of immature T cell proliferation in thymus GO:0033088
Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Negative regulation of immature T cell proliferation in thymus GO:0033088
Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Embryonic hindlimb morphogenesis GO:0035116
The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Tendon cell differentiation GO:0035990
The process in which a relatively unspecialized cell acquires the specialized features of a tendon cell. Tendon cell are elongated fibrocytes in which the cytoplasm is stretched between the collagen fibres of the tendon. Tendon cells have a central cell nucleus with a prominent nucleolus, a well-developed rough endoplasmic reticulum, and are responsible for synthesis and turnover of tendon fibres and ground substance.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Deltoid tuberosity development GO:0035993
The process whose specific outcome is the progression of the deltoid tuberosity over time, from its formation to the mature structure. The deltoid tuberosity is the region on the shaft of the humerus to which the deltoid muscle attaches. The deltoid tuberosity develops through endochondral ossification in a two-phase process; an initiating tendon-dependent phase, and a muscle-dependent growth phase.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
2 | P12644 (/IGI) P12644 (/IGI) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Regulation of odontogenesis of dentin-containing tooth GO:0042487
Any process that modulates the frequency, rate or extent of the formation and development of teeth, the hard, bony appendages which are borne on the jaws, or on other bones in the walls of the mouth or pharynx of most vertebrates.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Camera-type eye development GO:0043010
The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Camera-type eye development GO:0043010
The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Steroid hormone mediated signaling pathway GO:0043401
A series of molecular signals mediated by a steroid hormone binding to a receptor.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Steroid hormone mediated signaling pathway GO:0043401
A series of molecular signals mediated by a steroid hormone binding to a receptor.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
|
2 | P12644 (/TAS) P12644 (/TAS) |
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
2 | P12644 (/TAS) P12644 (/TAS) |
Cell fate commitment GO:0045165
The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of endothelial cell differentiation GO:0045603
Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of epidermal cell differentiation GO:0045606
Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of epidermal cell differentiation GO:0045606
Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of striated muscle tissue development GO:0045843
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of striated muscle tissue development GO:0045843
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P21275 (/TAS) P21275 (/TAS) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesodermal cell differentiation GO:0048333
The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Intermediate mesodermal cell differentiation GO:0048392
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Intermediate mesodermal cell differentiation GO:0048392
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Camera-type eye morphogenesis GO:0048593
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Embryonic morphogenesis GO:0048598
The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Anatomical structure formation involved in morphogenesis GO:0048646
The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Embryonic cranial skeleton morphogenesis GO:0048701
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Embryonic skeletal system development GO:0048706
The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of oligodendrocyte differentiation GO:0048715
Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Smooth muscle tissue development GO:0048745
The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Smooth muscle cell differentiation GO:0051145
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Regulation of smooth muscle cell differentiation GO:0051150
Any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Regulation of smooth muscle cell differentiation GO:0051150
Any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Cardiac muscle cell differentiation GO:0055007
The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
|
2 | P21275 (/NAS) P21275 (/NAS) |
Positive regulation of cardiac muscle fiber development GO:0055020
Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Positive regulation of cardiac muscle fiber development GO:0055020
Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle fiber development.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Inner ear receptor cell differentiation GO:0060113
The process in which relatively unspecialized cells, acquire specialized structural and/or functional features of inner ear receptor cells. Inner ear receptor cells are mechanorecptors found in the inner ear responsible for transducing signals involved in balance and sensory perception of sound.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Lens induction in camera-type eye GO:0060235
Signaling at short range between the head ectoderm and the optic vesicle that results in the head ectoderm forming a lens.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Embryonic skeletal joint morphogenesis GO:0060272
The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Embryonic skeletal joint morphogenesis GO:0060272
The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Cranial suture morphogenesis GO:0060363
The process in which any suture between cranial bones is generated and organized.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P21275 (/ISO) P21275 (/ISO) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Lung morphogenesis GO:0060425
The process in which the anatomical structures of the lung are generated and organized.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Lung morphogenesis GO:0060425
The process in which the anatomical structures of the lung are generated and organized.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Epithelium development GO:0060429
The process whose specific outcome is the progression of an epithelium over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Bronchus development GO:0060433
The biological process whose specific outcome is the progression of a bronchus from an initial condition to its mature state. This process begins with the formation of the bronchus and ends with the mature structure. The bronchus is the portion of the airway that connects to the lungs.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Bronchus development GO:0060433
The biological process whose specific outcome is the progression of a bronchus from an initial condition to its mature state. This process begins with the formation of the bronchus and ends with the mature structure. The bronchus is the portion of the airway that connects to the lungs.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Trachea development GO:0060438
The process whose specific outcome is the progression of a trachea over time, from its formation to the mature structure. The trachea is the portion of the airway that attaches to the bronchi as it branches.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Trachea development GO:0060438
The process whose specific outcome is the progression of a trachea over time, from its formation to the mature structure. The trachea is the portion of the airway that attaches to the bronchi as it branches.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Trachea formation GO:0060440
The process pertaining to the initial formation of a trachea from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the trachea is recognizable. The trachea is the portion of the airway that attaches to the bronchi as it branches.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Epithelial tube branching involved in lung morphogenesis GO:0060441
The process in which a highly ordered sequence of patterning events generates the branched epithelial tubes of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Epithelial tube branching involved in lung morphogenesis GO:0060441
The process in which a highly ordered sequence of patterning events generates the branched epithelial tubes of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Branching involved in prostate gland morphogenesis GO:0060442
The process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Bud elongation involved in lung branching GO:0060449
The process in which a bud in the lung grows out from the point where it is formed.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Epithelial cell proliferation involved in lung morphogenesis GO:0060502
The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population that contributes to the shaping of the lung.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Epithelial cell proliferation involved in lung morphogenesis GO:0060502
The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population that contributes to the shaping of the lung.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Bud dilation involved in lung branching GO:0060503
The process in which a bud in the lung increases radially.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Bud dilation involved in lung branching GO:0060503
The process in which a bud in the lung increases radially.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Prostate gland morphogenesis GO:0060512
The process in which the anatomical structures of a prostate gland are generated and organized.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mammary gland formation GO:0060592
The process pertaining to the initial formation of the mammary gland from unspecified parts. The process begins with formation of the mammary line and ends when the solid mammary bud invades the primary mammary mesenchyme.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Epithelial-mesenchymal cell signaling GO:0060684
Any process that results in the transfer of information from an epithelial cell to a mesenchymal cell where it is interpreted.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Negative regulation of prostatic bud formation GO:0060686
Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Negative regulation of prostatic bud formation GO:0060686
Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Regulation of branching involved in prostate gland morphogenesis GO:0060687
Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Regulation of morphogenesis of a branching structure GO:0060688
Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Coronary vasculature development GO:0060976
The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Coronary vasculature development GO:0060976
The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Regulation of cartilage development GO:0061035
Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Positive regulation of cartilage development GO:0061036
Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of cartilage development GO:0061036
Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of branching involved in lung morphogenesis GO:0061047
Any process that increases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
2 | P21275 (/IMP) P21275 (/IMP) |
BMP signaling pathway involved in ureter morphogenesis GO:0061149
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the shaping of the ureter. The ureter is a tube that extends from the kidney to the bladder.
|
2 | P21275 (/IDA) P21275 (/IDA) |
BMP signaling pathway involved in renal system segmentation GO:0061151
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the segmentation of the renal system.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Pulmonary artery endothelial tube morphogenesis GO:0061155
The process in which the anatomical structures of a tube are generated and organized from the pulmonary artery endothelium. An pulmonary artery endothelium is an epithelium that lines the pulmonary artery.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Pulmonary artery endothelial tube morphogenesis GO:0061155
The process in which the anatomical structures of a tube are generated and organized from the pulmonary artery endothelium. An pulmonary artery endothelium is an epithelium that lines the pulmonary artery.
|
2 | P21275 (/ISO) P21275 (/ISO) |
BMP signaling pathway involved in heart development GO:0061312
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the progression of the heart over time.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Negative regulation of thymocyte apoptotic process GO:0070244
Any process that stops, prevents, or reduces the frequency, rate or extent of thymocyte death by apoptotic process.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Negative regulation of thymocyte apoptotic process GO:0070244
Any process that stops, prevents, or reduces the frequency, rate or extent of thymocyte death by apoptotic process.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of hepatocyte differentiation GO:0070368
Any process that activates or increases the rate or extent of hepatocyte differentiation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Beak morphogenesis GO:0071729
The process in which the anatomical structures of the beak are generated and organized. The avian beak is an external anatomical structure, in the head region, that is adapted for feeding self and young, catching prey, probing, etc. It encompasses, but is not restricted to, the maxilla, mandible, maxillary rhamphotheca, mandibular rhamphotheca, nostril, nasal fossa, nasal bones, egg tooth and rictus.
|
2 | A5HMF8 (/IMP) Q90752 (/IMP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
2 | P21275 (/ISO) P21275 (/ISO) |
BMP signaling pathway involved in nephric duct formation GO:0071893
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to nephric duct formation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
BMP signaling pathway involved in nephric duct formation GO:0071893
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to nephric duct formation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Renal system development GO:0072001
The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.
|
2 | P12644 (/IEP) P12644 (/IEP) |
Glomerular visceral epithelial cell development GO:0072015
The process whose specific outcome is the progression of a glomerular visceral epithelial cell over time, from its formation to the mature structure. A glomerular visceral epithelial cell is a specialized epithelial cell that contains \feet\ that interdigitate with the \feet\ of other glomerular epithelial cells.
|
2 | P21275 (/IEP) P21275 (/IEP) |
Negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway GO:0072097
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor resulting in the reduction of the frequency, rate or extent of branch elongation involved in ureteric bud branching, the growth of a branch of the ureteric bud along its axis.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway GO:0072097
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor resulting in the reduction of the frequency, rate or extent of branch elongation involved in ureteric bud branching, the growth of a branch of the ureteric bud along its axis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway GO:0072101
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor that results in the establishment of the ureteric bud such that there is a similar arrangement in form and relationship of parts along its anterior/posterior axis.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway GO:0072101
A series of molecular signals generated as a consequence of any member of the BMP (bone morphogenetic protein) family binding to a cell surface receptor that results in the establishment of the ureteric bud such that there is a similar arrangement in form and relationship of parts along its anterior/posterior axis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Glomerular capillary formation GO:0072104
The process that gives rise to a glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesenchymal cell differentiation involved in kidney development GO:0072161
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the kidney as it progresses from its formation to the mature state.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Ureter epithelial cell differentiation GO:0072192
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell in the urothelium. The urothelium is the epithelial tube of the ureter.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Ureter smooth muscle cell differentiation GO:0072193
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell in the ureter.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of mesenchymal cell proliferation involved in ureter development GO:0072200
Any process that decreases the frequency, rate or extent of mesenchymal cell proliferation that contributes to the progression of the ureter gland over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of mesenchymal cell proliferation involved in ureter development GO:0072200
Any process that decreases the frequency, rate or extent of mesenchymal cell proliferation that contributes to the progression of the ureter gland over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Metanephric collecting duct development GO:0072205
The process whose specific outcome is the progression of a collecting duct in the metanephros over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. The collecting duct is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of kidney development GO:0090184
Any process that increases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of kidney development GO:0090184
Any process that increases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of branching involved in ureteric bud morphogenesis GO:0090191
Any process that decreases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Negative regulation of branching involved in ureteric bud morphogenesis GO:0090191
Any process that decreases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of glomerulus development GO:0090194
Any process that decreases the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of glomerulus development GO:0090194
Any process that decreases the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of store-operated calcium channel activity GO:1901341
Any process that activates or increases the frequency, rate or extent of store-operated calcium channel activity.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of cell proliferation involved in outflow tract morphogenesis GO:1901964
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Positive regulation of cell proliferation involved in outflow tract morphogenesis GO:1901964
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in outflow tract morphogenesis.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Positive regulation of mesenchymal stem cell proliferation GO:1902462
Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of pri-miRNA transcription by RNA polymerase II GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of pri-miRNA transcription by RNA polymerase II GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis GO:1905312
Any process that activates or increases the frequency, rate or extent of cardiac neural crest cell migration involved in outflow tract morphogenesis.
|
2 | P21275 (/IGI) P21275 (/IGI) |
Negative regulation of metanephric S-shaped body morphogenesis GO:2000005
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric S-shaped body morphogenesis.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of metanephric S-shaped body morphogenesis GO:2000005
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric S-shaped body morphogenesis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of metanephric comma-shaped body morphogenesis GO:2000007
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
|
2 | P12644 (/IDA) P12644 (/IDA) |
Negative regulation of metanephric comma-shaped body morphogenesis GO:2000007
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Negative regulation of cell proliferation involved in heart morphogenesis GO:2000137
Any process that stops, prevents, or reduces the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
|
2 | P12644 (/IMP) P12644 (/IMP) |
Negative regulation of cell proliferation involved in heart morphogenesis GO:2000137
Any process that stops, prevents, or reduces the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Mesenchymal cell differentiation involved in renal system development GO:2001012
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the renal system as it progresses from its formation to the mature state.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P21275 (/IMP) P21275 (/IMP) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | Q06826 (/IMP) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | Q06826 (/IEP) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | Q06826 (/NAS) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
1 | Q06826 (/NAS) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | Q06826 (/IEP) |
Polarity specification of dorsal/ventral axis GO:0009951
Any process resulting in the establishment of polarity along the dorsal/ventral axis.
|
1 | Q90752 (/NAS) |
Positive regulation of calcium ion transport into cytosol GO:0010524
Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
|
1 | Q06826 (/IMP) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q06826 (/IDA) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q06826 (/IMP) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | Q06826 (/IEP) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | Q06826 (/IEP) |
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
|
1 | Q06826 (/IEP) |
Response to testosterone GO:0033574
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
|
1 | Q06826 (/IEP) |
Cellular response to oxidative stress GO:0034599
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
1 | Q06826 (/IDA) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | Q06826 (/IEP) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
1 | Q06826 (/IEP) |
Tongue morphogenesis GO:0043587
The process in which the anatomical structures of the tongue are generated and organized. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in man other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech.
|
1 | Q06826 (/IEP) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
1 | Q06826 (/IDA) |
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
|
1 | Q06826 (/IMP) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
1 | Q06826 (/IMP) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
1 | Q06826 (/IMP) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | Q90752 (/NAS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | Q90752 (/IMP) |
Intermediate mesodermal cell differentiation GO:0048392
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
|
1 | Q90752 (/NAS) |
Negative regulation of oligodendrocyte differentiation GO:0048715
Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.
|
1 | Q06826 (/IMP) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
1 | Q06826 (/IEP) |
Anatomical structure regression GO:0060033
The developmental process in which an anatomical stucture is destroyed as a part of its normal progression.
|
1 | Q06826 (/IEP) |
Retina development in camera-type eye GO:0060041
The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
|
1 | Q06826 (/IEP) |
Epithelial tube branching involved in lung morphogenesis GO:0060441
The process in which a highly ordered sequence of patterning events generates the branched epithelial tubes of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
1 | Q06826 (/IEP) |
Lung lobe development GO:0060462
The biological process whose specific outcome is the progression of a lung lobe from an initial condition to its mature state. This process begins with the formation of a lung lobe by branching morphogenesis and ends with the mature structure. A lung lobe is one of the rounded projections that compose the lung.
|
1 | Q06826 (/IEP) |
Ureteric bud morphogenesis GO:0060675
The process in which the ureteric bud is generated and organized.
|
1 | Q90752 (/IEP) |
Positive regulation of hepatocyte differentiation GO:0070368
Any process that activates or increases the rate or extent of hepatocyte differentiation.
|
1 | Q06826 (/IMP) |
Regulation of ERK1 and ERK2 cascade GO:0070372
Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | Q06826 (/IDA) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | Q06826 (/IEP) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
1 | Q06826 (/IDA) |
Response to nitric oxide GO:0071731
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
|
1 | Q06826 (/IEP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
1 | Q06826 (/IEP) |
Nephric duct formation GO:0072179
The developmental process pertaining to the initial formation of a nephric duct. A nephric duct is a tube that drains a primitive kidney.
|
1 | Q90752 (/IMP) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
1 | Q06826 (/IMP) |
Cellular response to thyroid hormone stimulus GO:0097067
A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
|
1 | Q06826 (/IEP) |
Positive regulation of store-operated calcium channel activity GO:1901341
Any process that activates or increases the frequency, rate or extent of store-operated calcium channel activity.
|
1 | Q06826 (/IMP) |
Positive regulation of mesenchymal stem cell proliferation GO:1902462
Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation.
|
1 | Q06826 (/IMP) |
Regulation of myotome development GO:2000290
Any process that modulates the frequency, rate or extent of myotome development.
|
1 | Q90752 (/NAS) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
1 | Q06826 (/IMP) |
Positive regulation of progesterone secretion GO:2000872
Any process that activates or increases the frequency, rate or extent of progesterone secretion.
|
1 | Q90752 (/TAS) |
There are 11 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
5 | P12644 (/IDA) P12644 (/IDA) P21275 (/IDA) P21275 (/IDA) Q06826 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P21275 (/IDA) P21275 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P12644 (/TAS) P12644 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P12644 (/ISS) P12644 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
|
2 | P12644 (/TAS) P12644 (/TAS) |
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
|
2 | P21275 (/ISO) P21275 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q06826 (/IDA) |
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
|
1 | Q06826 (/IDA) |